$AXON

SMITH PATRICK W sold $5.4M of AXON

SMITH PATRICK W (CHIEF EXECUTIVE OFFICER) sold 9,930 shares of AXON ENTERPRISE, INC. (AXON) at an average of $548.77 ($526.52–$565.65, $5.45M total) across 30 trades on 2026-08-07 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SMITH PATRICK W
Published Aug 11, 2026, 8:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

The CEO’s open-market sale totaling $5.45M is disclosed with a pre-arranged 10b5-1 plan, which generally lowers the likelihood of new negative information about Axon’s prospects.

02

Market read

Traders may monitor insider activity for sentiment, but this specific disclosure is unlikely to drive a major repricing given the 10b5-1 structure.

03

What to watch

The filing does not state proceeds use, tax context, or whether other insiders sold/bought around the same time, so the net read-through is uncertain.

Relevance 5/10Novelty 3/10Timing: filed Aug 11, covering sales executed Aug 7

Background

The article is an SEC Form 4 insider transaction disclosure for Axon Enterprise, Inc.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon CEO Smith Patrick W sold about 9,930 shares in an open-market transaction totaling $5.45M, under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect should be modest and sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan, which typically implies reduced informational content versus discretionary selling.

Market effects

Minimal. Insider selling at a single company does not materially change the broader sector outlook.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, traders may ignore it entirely and focus on operational catalysts rather than insider flow.

Key entities

  • AXON ENTERPRISE, INC.

    Company whose CEO insider sale is reported on Form 4.

  • SMITH PATRICK W

    Chief Executive Officer and director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AXONHighAI 9/10

Axon’s (AXON) Dilution Fears Look Overstated

Axon Enterprise (AXON) stock fell after announcing a $1B convertible-note offering, but analysts argue dilution fears are overstated. The notes carry 0% interest, convert at $652.06, and are hedged to $1,049.94. Q2 revenue rose 35% to $904M, marking 10 straight quarters of over 30% growth. Management raised full-year revenue growth outlook to 32-34%. AXON has a Strong Buy consensus rating, with an average price target of $719.55.

$AXONHighAI 8/10

Why Did Axon Stock Fall Ten Percent On A Convertible That Pays No Interest?

Axon Enterprise (AXON) shares dropped 9.8% after announcing a $1.0 billion convertible note offering with a 0% coupon. The market interpreted this as a sign of cash flow challenges despite strong revenue growth (34.6% YoY). The company cited inventory investments and rising component costs. AXON's stock is now 43% below its 52-week high, trading at 11x trailing revenue with shrinking margins.

$AXONHighAI 9/10

Axon Q2FY26 Results: Revenue rises 35% to $904 million, guidance raised

Axon Enterprise reported Q2FY26 revenue of $904M, up 35% YoY, and raised full-year guidance to 32-34% growth. Software & services revenue rose 36% to $398M, while connected devices revenue grew 35% to $507M. Platform solutions revenue surged 123% to $150M. The company plans a $1B convertible note offering due 2031, with net proceeds for general corporate purposes and capped call transactions. Shares were up 0.50% in premarket trading.

$AXONHighAI 8/10

Full Transcript: Axon Enterprise Q2 2026 Earnings Call - (AXON)

Axon Enterprise (AXON) reported a record Q2 2026 with 39% growth, driven by demand for Dedrone, Taser 10, and Axon Body 4. The company raised its full-year revenue guidance to 32-34% growth, citing strong bookings and market expansion. Management highlighted investments in AI and public safety technologies, emphasizing trust and data privacy.

$AXONMedAI 8/10

Axon Rebounded 6% Wednesday. Here’s What Could Drive the Stock Through 2026

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.